Match!
Akira Akabayashi
University of Tokyo
11Publications
1H-index
3Citations
Publications 11
Newest
#1Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
#2Keiichiro Yamamoto (UTokyo: University of Tokyo)H-Index: 1
Last.Akira AkabayashiH-Index: 1
view all 6 authors...
In this article, we perform a thought experiment about living donor kidney transplantation. If a living kidney donor becomes in need of renal replacement treatment due to dysfunction of the remaining kidney after donation, can the donor ask the recipient to give back the kidney that had been donated? We call this problem organ restitution and discussed it from the ethical viewpoint. Living organ transplantation is a kind of ‘designated donation’ and subsequently has a contract-like character. Fi...
Source
#1Akira Akabayashi (UTokyo: University of Tokyo)H-Index: 1
1 CitationsSource
#1Akira Akabayashi (NYU: New York University)H-Index: 1
#2Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
Last.Hiroyasu Ino (UTokyo: University of Tokyo)
view all 3 authors...
Source
#1Akira Akabayashi (NYU: New York University)H-Index: 1
#2Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
Last.Aru Akabayashi (UTokyo: University of Tokyo)H-Index: 1
view all 3 authors...
In April 2018, Japan’s first law regulating clinical research went into effect. The law aimed to strengthen regulations on research integrity and conflicts of interest, which had been limited under existing administrative guidelines; the law also provided stipulations for legal penalties. The scope of the new regulations, however, is limited entirely to studies that evaluate unapproved drugs or the off-label use of approved drugs, and those that receive funding from companies. On the other hand,...
Source
#1Akira AkabayashiH-Index: 1
#2Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
Last.Nancy S. JeckerH-Index: 24
view all 3 authors...
In the January edition of the Journal of Medical Ethics, Fujita and Tabuchi (hereafter, Authors) responded that we misunderstood the ‘facts’ in our previous article. Our article’s method was twofold. First, it appealed to normative analysis and publicly accessible materials, and second, it targeted a policy-making approach to public funding. We specifically did not focus on the Center for iPS Cell Research and Application or induced pluripotent stem stock projects. The Authors raised five critic...
Source
#2Misao FujitaH-Index: 8
Last.Akira AkabayashiH-Index: 1
view all 7 authors...
Introduction: Although guidelines do not recommend chemotherapy for patients with advanced cancer when death is imminent, many reports suggest the tendency to continue this treatment has been increasing every year. This study aimed to construct a model to clarify the beliefs and communication of doctors who administer chemotherapy to patients with recurrent or metastatic (hereafter, “recurrent/metastatic”) breast cancer, and determine how these beliefs are related to the process of treating pati...
Source
#1Akira Akabayashi (UTokyo: University of Tokyo)H-Index: 1
#2Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
Last.Nancy S. Jecker (UW: University of Washington)H-Index: 24
view all 3 authors...
We examine the ethics of using induced pluripotent stem cells (iPSCs) in cell transplantation treatment of neurologic diseases and the essential types of ethical benchmarks required in clinical trials in neurology using iPSCs, including embryonic pluripotent stem cells. We focus on two issues: (1) comparison and (2) criticism of the two types of neuro-hype (neuro-purism and neuro-essentialism). In order to ensure that the dialog on ethical benchmarks continues to develop in a manner that promote...
Source
#1Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
#2Keiichiro Yamamoto (UTokyo: University of Tokyo)H-Index: 1
Last.Akira Akabayashi (NYU: New York University)H-Index: 1
view all 4 authors...
1 CitationsSource
#1Akira AkabayashiH-Index: 1
#2Eisuke NakazawaH-Index: 3
Last.Arthur L. CaplanH-Index: 47
view all 3 authors...
Source
#1Eisuke Nakazawa (UTokyo: University of Tokyo)H-Index: 3
#2Shoichi Maeda (Keio: Keio University)H-Index: 5
Last.Akira Akabayashi (NYU: New York University)H-Index: 1
view all 8 authors...
This paper examines the ethical aspects of organ transplant surgery in which a donor heart is transplanted from a first recipient, following determination of death by neurologic criteria, to a second recipient. Retransplantation in this sense differs from that in which one recipient undergoes repeat heart transplantation of a newly donated organ, and is thus referred to here as “reuse cardiac organ transplantation.” Medical, legal, and ethical analysis, with a main focus on ethical analysis. Fro...
1 CitationsSource
12